Department of Gastroenterology, Cemi Demiroğlu Bilim University, Istanbul, Turkey.
School of Medicine, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey.
J Viral Hepat. 2023 Jul;30(7):588-596. doi: 10.1111/jvh.13834. Epub 2023 Mar 28.
Hepatitis D virus (HDV) infection represents the most serious form of chronic hepatitis. Turkey is among the countries with high HDV and intermediate hepatitis B virus prevalence. In Turkey, hepatitis B virus (HBV) vaccine series was included in the routine vaccination program in 1998. There have been regional differences in prevalence of HBV and HDV. Although a decline in HDV prevalence is estimated, there are uncertainties about the epidemic patterns of it. HDV prevalence was studied in varying groups and geographic regions. In this study, we aimed to analyse hepatitis D epidemiology in all groups and geographic regions in recent 35 years. During the study period of 35 years, 111 publications were noted. The analysis was done on the basis of three periods: 1999 and before (Period 1), 2000-2009 (Period 2), and 2010 and after (Period 3). The groups studied included inactive carrier state, chronic hepatitis B, all HBsAg-positive individuals and special groups. Among inactive HBV carriers, HDV prevalence did not change significantly over three decades. Among patients with chronic hepatitis, studies reported decreasing (from Period 1 to Period 2) and then increasing (from Period 2 to period 3) HDV prevalence. The studies including all HBsAg-positive patients reported decreasing (from Period 1 to Period 2) and then increasing (from Period 2 to period 3) HDV prevalence. Cumulative data of these 3 groups were taken to reveal HDV prevalence in HBV-infected patients, and it showed decreasing (from Period 1 to Period 2) and then increasing (from Period 2 to period 3) HDV prevalence. Cumulative data of these 3 groups analysed according to the geographic regions of the country showed that Eastern and Southeastern Anatolia regions still have a high burden of HDV. The study showed that although HDV prevalence decreased from 8.3% in Period 1 to 4.8% in Period 2, it tended to increase 5.5% in Period 3. HDV infection is still a healthcare problem in Turkey.
丁型肝炎病毒(HDV)感染是慢性肝炎中最严重的一种形式。土耳其是 HDV 和乙型肝炎病毒(HBV)高流行率的国家之一。1998 年,土耳其将 HBV 疫苗系列纳入常规疫苗接种计划。HBV 和 HDV 的流行率在不同地区存在差异。尽管预计 HDV 的流行率会下降,但对其流行模式仍存在不确定性。HDV 的流行率在不同的群体和地理区域进行了研究。在这项研究中,我们旨在分析最近 35 年来所有群体和地理区域的丁型肝炎流行病学。在 35 年的研究期间,共记录了 111 篇出版物。分析基于三个时期进行:1999 年及以前(第 1 时期)、2000-2009 年(第 2 时期)和 2010 年及以后(第 3 时期)。研究的群体包括非活动性携带者状态、慢性乙型肝炎、所有 HBsAg 阳性个体和特殊群体。在非活动性 HBV 携带者中,30 年来 HDV 的流行率没有明显变化。在慢性乙型肝炎患者中,研究报告称 HDV 的流行率先下降(从第 1 时期到第 2 时期),然后上升(从第 2 时期到第 3 时期)。包括所有 HBsAg 阳性患者的研究报告称 HDV 的流行率先下降(从第 1 时期到第 2 时期),然后上升(从第 2 时期到第 3 时期)。将这 3 组的累积数据合并,以揭示 HBV 感染者中的 HDV 流行率,结果显示 HDV 的流行率先下降(从第 1 时期到第 2 时期),然后上升(从第 2 时期到第 3 时期)。根据该国的地理区域对这 3 组的累积数据进行分析后发现,东安纳托利亚和东南安纳托利亚地区仍有很高的 HDV 负担。研究表明,尽管 HDV 的流行率从第 1 时期的 8.3%下降到第 2 时期的 4.8%,但在第 3 时期有上升的趋势,达到 5.5%。HDV 感染仍然是土耳其的一个医疗保健问题。